ArticleBMC neurology2025
Burden of meningitis and encephalitis in Iran from 1990 to 2021: findings from the Global Burden of Disease study.
Article in BMC neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMeningitis and encephalitis are significant contributors to morbidity and mortality worldwide. This study aimed to provide a comprehensive overview of the trends and epidemiology of these diseases in Iran from 1990 to 2021.
methodsData from the Global Burden of Disease (GBD) study were utilized to assess the epidemiology and burden of meningitis and encephalitis in Iran. This study compared these findings with those of global and Middle East and North Africa (MENA) countries. Age-standardized rates for incidence, prevalence, and disability-adjusted life years (DALYs) were calculated, and trends over time were analyzed.
resultsThis study revealed a substantial reduction in the burden of meningitis over the observed period, with a -85.81% decrease in age-standardized DALYs rates from 1990 to 2021. Encephalitis rates also decreased, though to a lesser extent. Significant disparities in disease burden were observed across different sexes and age groups, with higher rates among males and in the < 5 years and ≥ 90 years' age groups. Provincial disparities were also noted, with the highest age-standardized DALYs rates for meningitis in provinces such as Sistan and Baluchistan, Kohgiluyeh and Boyer-Ahmad, and Hamadan.
conclusionThis study highlights the progress made in reducing the burden of meningitis and encephalitis in Iran over the past three decades. However, the observed disparities across sexes, age groups, and provinces emphasize the need for continued efforts in surveillance, prevention, and treatment to further alleviate the impact of these diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.